Immunotherapy

Community Translations

More success for immunotherapy with nivolumab approval for metastatic RCC

Author:: Edited Jame Abraham

Read More

Feature

Encouraging data on immunotherapy, cardiotoxicity, and DFS

Author:: Bruce Jancin et al

Read More

MD IQ

Quiz: Targeting the necrosome for cancer therapy

From the Editor

Making immunotherapy part of routine breast cancer treatment

Author:: Jame Abraham

Read More

New Therapies

Entering an era of intelligent combination therapy in cancer

Author:: Jane De Lartigue

Read More

Community Translations

Dinutuximab combination therapy becomes first approval for high-risk neuroblastoma

Author:: Edited Jame Abraham; Report Prepared Jane De Lartigue

Read More

Community Translations

Nivolumab: first immunotherapy approved for lung cancer

Author:: Edited Jame Abraham; Report Prepared Jane De Lartigue

Read More

Feature

Harnessing new data on immunotherapies

Author:: Susan London et al

Read More

Feature

Oncogenic drivers and immunotherapy: staying one step ahead of lung cancer

Author:: Jane De Lartigue

Read More

From the Editor

ASCO 2015: from data and learning, to daily practice

Author:: Howard A Burris III

Read More

Feature

Immunotherapy moves into the breast cancer landscape

Author:: Bruce Jancin et al

Read More

Pages

All Specialties